Can inflammatory signaling reduce peripheral T4-to-T3 conversion and cause low T3 despite normal free T4?

Systemic inflammation is a primary driver of Non-Thyroidal Illness Syndrome (NTIS), a condition characterized by significant shifts in thyroid hormone metabolism without intrinsic thyroid gland dysfunction. For a 37-year-old female, understanding how inflammatory signaling alters these pathways is crucial for interpreting thyroid labs that appear "suboptimal" despite normal TSH and T4 levels.

Clinical and mechanistic evidence

The hallmark of inflammation-induced thyroid dysregulation is a reduction in serum triiodothyronine (T3) levels while thyroxine (T4) remains within the reference range.

• Deiodinase inhibition: Pro-inflammatory cytokines, specifically interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and interleukin-1 (IL-1), directly inhibit the activity of Type 1 (DIO1) and Type 2 (DIO2) deiodinase enzymes. These enzymes are responsible for the peripheral conversion of T4 (the pro-hormone) into T3 (the active hormone).
• Molecular pathways: These cytokines operate through nuclear factor-kappa B (NF-κB) and mitogen-activated protein (MAP) kinase pathways. When activated, these pathways suppress the gene expression and enzymatic activity of deiodinases in key tissues like the liver and kidneys.
• Cofactor depletion: Systemic inflammation increases oxidative stress, which can deplete thiol-containing cofactors (such as glutathione) necessary for the deiodination process, further impairing T3 production.
• Alternate pathways: Inflammation often shifts metabolism toward the production of Reverse T3 (rT3), an inactive isomer, by maintaining or increasing Type 3 deiodinase (DIO3) activity, which further lowers available active T3.

Clinical implications

Research across various populations confirms a strong negative correlation between inflammatory markers (like C-reactive protein and IL-6) and free T3 levels. In mild-to-moderate inflammatory states, the "low T3/normal T4" pattern is the most common manifestation. While this is often viewed as an adaptive mechanism to conserve energy during illness, chronic low-grade inflammation may lead to persistent T3 deficiency at the cellular level despite "normal" standard thyroid panels.

Bottom line

Inflammatory signaling directly impairs the peripheral conversion of T4 to T3 by inhibiting deiodinase enzymes. This frequently results in a low T3 pattern despite normal free T4, serving as a biological marker of systemic inflammatory stress.